Hints and tips:
Related Special Reports
...From customer service chatbots to data migration and overhauling research and development in healthcare, Schweizer said BCG is helping companies use AI to cut costs and increase productivity....
...Roughly a quarter of the funding comes via an equity investment, with the remainder composed of research grants and commitments for joint business development that will not dilute shareholders, said people...
...The Development Bank of Japan is investing in 4Bio, which funds companies in the UK and Europe, alongside the Japanese pharma group Kyowa Kirin, and US healthcare provider, Children’s Minnesota. 4Bio aims...
...Dementia Mission and chief executive of Alzheimer’s Research UK....
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
...This will include research, models, computing power and those responsible for overseeing their accuracy and trustworthiness....
...“Familiarity bias” means investors tend to have more exposure to stocks they know and less diverse portfolios, academic research shows....
...Specification: Cognition and Development Click the link below to read the and then answer the questions: US seeks up to 50-year sentence for FTX founder Sam Bankman-Fried According to his lawyers quoted...
...The Cupertino-based company last week announced it was upgrading its Shanghai research centre and opening a laboratory in Shenzhen to work on research and testing for its iPhone, iPad and Vision Pro product...
...The research charity noted there had been improvements in diagnosing and treating the disease in the years since the latest trial, conducted by the universities of Bristol, Oxford and Cambridge, began....
...The results from the research, which involved 156 people, were a “major breakthrough”, said Olivier Rascol, a Toulouse University Hospital professor and a co-author of the research with Prof Wassilios Meissner...
...But she adds, “The whole ecosystem is costly, from the research and development phase to production.”...
...A dearth of career scientists and public funding risks undermining efforts to use technological breakthroughs to tackle the biggest health threats, the head of a leading international research organisation...
...Martin Holst Lange, head of development at Novo Nordisk, said that Cardior’s drug had the “potential to become a first-in-class therapy designed to halt or partially reverse the course of disease for people...
...Thomson is a professor of experimental particle physics at the University of Cambridge and executive chair of the Science and Technology Facilities Council, a UK research organisation....
...Apple says it has been accelerating its research and development, spending nearly $30bn last year, with a fivefold increase in spending over the past 10 years....
...Jodie Keane Senior Research Fellow ODI (Formerly Overseas Development Institute), London SE1, UK...
...With over $155bn in cash at the plan’s inception, Apple had the funds and reputation to pose a credible threat to the car industry. The company has ramped up research spend....
...Susan Galbraith, executive vice-president of oncology research and development at AstraZeneca, said there was an “opportunity to improve” on existing drugs in the area and that the Fusion acquisition would...
...The UK government said in a statement: “Research and the life sciences are crucial in the fight against cancer, which is why we invest £1bn per year through the National Institute for Health and Care Research...
...The reliance on animal testing brings further risks to the human subjects of clinical trials, and to the drug development process as a whole, Quantiphi argued....
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
...Drew Baglino, senior vice-president leading Tesla’s engineering and technology development for batteries, motors and energy products, announced on X today that he would leave after 18 years at the auto group...
...Wegovy has been on sale since only 2021 and Zepbound was approved just five months ago, but Novo Nordisk and Eli Lilly are already leading the development of the next generation of weight-loss drugs....
International Edition